Article
DAMP Signaling and Immunogenic Cell Death in Glioblastoma: Radiotherapy-Induced Immune Reprogramming and Opportunities for Personalized Treatment
2026-01-05
Abstract excerpt
Glioblastoma (GBM) remains among the most treatment-refractory human malignancies, shaped by profound molecular heterogeneity, extensive genomic instability and an immunosuppressive tumor microenvironment. Radiotherapy represents a cornerstone of current management; however, its therapeutic benefit is frequently limited by adaptive resistance and ineffective antitumor immunity. Emerging evidence indicates that ion...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 85927596-1765-5909-9ac3-5375d13f3f7c
- DOI
- 10.20944/preprints202601.0307.v1
